Skip to main content
OpenTrials

Clinical trial condition

Triple Negative Breast Cancer

Explore clinical trials studying Triple Negative Breast Cancer. Study availability and eligibility vary by location and protocol.

294 public trials 113 recruiting studies
Refine in advanced search Browse all conditions

Triple Negative Breast Cancer trial results

Active, Not Recruiting

Sacituzumab Govitecan in Primary HER2-negative Breast Cancer

NCT04595565

Conditions
Breast Diseases, Breast Neoplasms, HER2-negative Breast Cancer, +6 more
Locations
  • MUG - Univ.-Klinik f. Frauenheilkunde u. Geburtshilfe Graz Graz, Austria
  • MUG - Univ.-Klinik f. Innere Medizin Graz Graz, Austria
  • MUI - Univ. Klinik f. Frauenheilkunde Innsbruck Innsbruck, Austria
  • Ordensklinikum Linz GmbH - BHS Linz, Austria
View all 163 locations
View Trial Details
Active, Not Recruiting

Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreated Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer

NCT05382299

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +6 more
Locations
  • Arizona Oncology Associates, PC-Hope,1845 W Orange Grove Rd Tucson, Arizona, United States
  • Arizona Oncology Associates, PC-Hope,2070 W. Rudasill Rd. Tucson, Arizona, United States
  • Arizona Oncology Associates, PC-Hope Tucson, Arizona, United States
  • Arizona Oncology Associates, PC-Hope,1620 West St. Mary's Road Tucson, Arizona, United States
View all 363 locations
View Trial Details
Active, Not Recruiting

Randomized Study of Stereotactic Body Radiation Therapy (SBRT) in Patients With Oligoprogressive Metastatic Cancers of the Breast and Lung

NCT03808662

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +19 more
Locations
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack Commack, New York, United States
View Trial Details
Active, Not Recruiting

Study of Safety and Efficacy of DKY709 Alone or in Combination With PDR001 in Patients With Advanced Solid Tumors.

NCT03891953

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +33 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
  • Novartis Investigative Site Dresden, Saxony, Germany
View Trial Details
Active, Not Recruiting

Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400

NCT06084481

Conditions
Adenocarcinoma, Biliary Tract Cancers, Biliary Tract Diseases, +31 more
Locations
  • City of Hope National Medical Center /ID# 258645 Duarte, California, United States
  • Ucsf /Id# 257705 San Francisco, California, United States
  • University of Colorado Cancer Center - Cancer Clinical Trials Office /ID# 255128 Aurora, Colorado, United States
  • Sarah Cannon Research Institute at HealthONE - Denver /ID# 258926 Denver, Colorado, United States
View all 54 locations
View Trial Details

Related conditions